FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3003085814> ?p ?o ?g. }

• W3003085814 endingPage "323" @default.
• W3003085814 startingPage "313" @default.
• W3003085814 abstract "There is an unmet medical need for a safe and effective weight loss product with minimal systemic side-effects. In this study, the effect of a novel modified-release fixed-dose combination of orlistat and acarbose (MR-OA) was compared with conventional orlistat (CO) regarding tolerability, appetite and glucose metabolism.Sixty-seven men with obesity, aged 24 to 60 years with body mass indexes (BMIs) 33 to 40 kg m-2 or BMIs 30 to 32 kg m-2 and waist circumference above 102 cm were included. They were randomized to either three different doses of the test formulation MR-OA (60 mg orlistat/20 mg acarbose, 90/30 and 120/40) or CO (Xenical, 120 mg orlistat) for a 2-week study of daily treatment. The participants spent days 1 and 14 at the clinical research centre where they received standardized meals, had blood sampling and filled in questionnaires regarding tolerability and appetite after meals. In days 2 to 13, the participants were at home and continued to fill in the questionnaires daily.In the MR-OA groups, reports of liquid and oily stools as well as faecal incontinence were fewer, whereas reports of gastric distension and flatulence were higher, compared with the CO group. More participants reported decreased hunger in the 90/30 and 120/40 MR-OA, and postprandial plasma glucose concentration was reduced in all MR-OA groups compared with CO.This study shows that by using a modified-release dosage form, orlistat and acarbose can be combined without compromising tolerability. Furthermore, MR-OA shows promising effects regarding reduction of appetite and reduces postprandial glucose. Tolerability is coupled to compliance and thereby efficacy of a treatment; therefore, this novel combination MR-OA could be an effective approach for weight loss treatment. A follow-up study in a more diverse population and for a longer duration with weight loss as primary outcome variable is planned." @default.
• W3003085814 created "2020-01-30" @default.
• W3003085814 creator A5003164160 @default.
• W3003085814 creator A5016057474 @default.
• W3003085814 creator A5027228958 @default.
• W3003085814 creator A5034860925 @default.
• W3003085814 creator A5065307928 @default.
• W3003085814 creator A5076981178 @default.
• W3003085814 creator A5088832801 @default.
• W3003085814 date "2020-02-07" @default.
• W3003085814 modified "2023-10-09" @default.
• W3003085814 title "Effects of a novel combination of orlistat and acarbose on tolerability, appetite, and glucose metabolism in persons with obesity" @default.
• W3003085814 cites W1809760566 @default.
• W3003085814 cites W1961977850 @default.
• W3003085814 cites W1972181316 @default.
• W3003085814 cites W1977118015 @default.
• W3003085814 cites W1987282451 @default.
• W3003085814 cites W1987319550 @default.
• W3003085814 cites W1989330268 @default.
• W3003085814 cites W1993708032 @default.
• W3003085814 cites W1995102460 @default.
• W3003085814 cites W1995734772 @default.
• W3003085814 cites W1997595732 @default.
• W3003085814 cites W2003543252 @default.
• W3003085814 cites W2005697725 @default.
• W3003085814 cites W2008978729 @default.
• W3003085814 cites W2016716501 @default.
• W3003085814 cites W2018556687 @default.
• W3003085814 cites W2028274580 @default.
• W3003085814 cites W2029664864 @default.
• W3003085814 cites W2034738477 @default.
• W3003085814 cites W2040123871 @default.
• W3003085814 cites W2040812359 @default.
• W3003085814 cites W2043824932 @default.
• W3003085814 cites W2047352716 @default.
• W3003085814 cites W2053187611 @default.
• W3003085814 cites W2055328904 @default.
• W3003085814 cites W2072876144 @default.
• W3003085814 cites W2075449484 @default.
• W3003085814 cites W2079612622 @default.
• W3003085814 cites W2079929562 @default.
• W3003085814 cites W2088721312 @default.
• W3003085814 cites W2089623601 @default.
• W3003085814 cites W2096795532 @default.
• W3003085814 cites W2101675653 @default.
• W3003085814 cites W2109167260 @default.
• W3003085814 cites W2115501504 @default.
• W3003085814 cites W2121499324 @default.
• W3003085814 cites W2123744385 @default.
• W3003085814 cites W2124940920 @default.
• W3003085814 cites W2126470550 @default.
• W3003085814 cites W2142527051 @default.
• W3003085814 cites W2154247599 @default.
• W3003085814 cites W2155431359 @default.
• W3003085814 cites W2157135485 @default.
• W3003085814 cites W2158430148 @default.
• W3003085814 cites W2158803184 @default.
• W3003085814 cites W2192722195 @default.
• W3003085814 cites W2262342017 @default.
• W3003085814 cites W2288349424 @default.
• W3003085814 cites W2409887465 @default.
• W3003085814 cites W2432501512 @default.
• W3003085814 cites W2580828568 @default.
• W3003085814 cites W2756152366 @default.
• W3003085814 cites W2764147799 @default.
• W3003085814 cites W2766795193 @default.
• W3003085814 cites W2791667241 @default.
• W3003085814 cites W2927187623 @default.
• W3003085814 cites W2950797496 @default.
• W3003085814 cites W2967788962 @default.
• W3003085814 doi "https://doi.org/10.1002/osp4.405" @default.
• W3003085814 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7278902" @default.
• W3003085814 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32523721" @default.
• W3003085814 hasPublicationYear "2020" @default.
• W3003085814 type Work @default.
• W3003085814 sameAs 3003085814 @default.
• W3003085814 citedByCount "16" @default.
• W3003085814 countsByYear W30030858142020 @default.
• W3003085814 countsByYear W30030858142021 @default.
• W3003085814 countsByYear W30030858142022 @default.
• W3003085814 countsByYear W30030858142023 @default.
• W3003085814 crossrefType "journal-article" @default.
• W3003085814 hasAuthorship W3003085814A5003164160 @default.
• W3003085814 hasAuthorship W3003085814A5016057474 @default.
• W3003085814 hasAuthorship W3003085814A5027228958 @default.
• W3003085814 hasAuthorship W3003085814A5034860925 @default.
• W3003085814 hasAuthorship W3003085814A5065307928 @default.
• W3003085814 hasAuthorship W3003085814A5076981178 @default.
• W3003085814 hasAuthorship W3003085814A5088832801 @default.
• W3003085814 hasBestOaLocation W30030858141 @default.
• W3003085814 hasConcept C126322002 @default.
• W3003085814 hasConcept C134018914 @default.
• W3003085814 hasConcept C197934379 @default.
• W3003085814 hasConcept C2775913212 @default.
• W3003085814 hasConcept C2776193436 @default.
• W3003085814 hasConcept C2776617576 @default.
• W3003085814 hasConcept C2778199505 @default.
• W3003085814 hasConcept C2778375690 @default.

• next